These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Molecular Analysis of BRCA1 in Human Breast Cancer Cells Under Oxidative Stress. Gilmore BL, Liang Y, Winton CE, Patel K, Karageorge V, Varano AC, Dearnaley W, Sheng Z, Kelly DF. Sci Rep; 2017 Mar 06; 7():43435. PubMed ID: 28262780 [Abstract] [Full Text] [Related]
43. Structural dynamics of clinically-reported VUS in the BARD1 ARD-BRCT region to predict the molecular basis of alterations. Barua SA, Choudhary RK, Gawde J, Mishra N, Varma AK. J Biomol Struct Dyn; 2024 Jul 06; 42(11):5475-5484. PubMed ID: 37418175 [Abstract] [Full Text] [Related]
44. In silico investigation on the mutational analysis of BRCA1-BARD1 RING domains and its effect on nucleosome recognition and ubiquitination. Sarma H, Kiewhuo K, Jamir E, Sastry GN. Biophys Chem; 2023 Sep 06; 300():107070. PubMed ID: 37339533 [Abstract] [Full Text] [Related]
47. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1. Pyrpassopoulos S, Ladopoulou A, Vlassi M, Papanikolau Y, Vorgias CE, Yannoukakos D, Nounesis G. Biophys Chem; 2005 Apr 01; 114(1):1-12. PubMed ID: 15792855 [Abstract] [Full Text] [Related]
50. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Baer R, Ludwig T. Curr Opin Genet Dev; 2002 Feb 01; 12(1):86-91. PubMed ID: 11790560 [Abstract] [Full Text] [Related]
51. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1. Gaiser OJ, Ball LJ, Schmieder P, Leitner D, Strauss H, Wahl M, Kühne R, Oschkinat H, Heinemann U. Biochemistry; 2004 Dec 28; 43(51):15983-95. PubMed ID: 15609993 [Abstract] [Full Text] [Related]
54. BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1. Witus SR, Burrell AL, Farrell DP, Kang J, Wang M, Hansen JM, Pravat A, Tuttle LM, Stewart MD, Brzovic PS, Chatterjee C, Zhao W, DiMaio F, Kollman JM, Klevit RE. Nat Struct Mol Biol; 2021 Mar 28; 28(3):268-277. PubMed ID: 33589814 [Abstract] [Full Text] [Related]
55. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Williams RS, Lee MS, Hau DD, Glover JN. Nat Struct Mol Biol; 2004 Jun 28; 11(6):519-25. PubMed ID: 15133503 [Abstract] [Full Text] [Related]
56. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex. Varma AK, Brown RS, Birrane G, Ladias JA. Biochemistry; 2005 Aug 23; 44(33):10941-6. PubMed ID: 16101277 [Abstract] [Full Text] [Related]
57. Oncogenic BARD1 isoforms expressed in gynecological cancers. Li L, Ryser S, Dizin E, Pils D, Krainer M, Jefford CE, Bertoni F, Zeillinger R, Irminger-Finger I. Cancer Res; 2007 Dec 15; 67(24):11876-85. PubMed ID: 18089818 [Abstract] [Full Text] [Related]